Chemours Co (CC)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $2.00B
Last updated: Nov 17, 2026 at 11:04 AM ET
Chemours Co (CC) Financials: Revenue, Profit and Cash Flow
Chemours reported revenue of $5.81B for the fiscal year ended Dec 31, 2025, up 0.4% from the year before. That year, net income was -$386.00M with a net margin of -6.6%, operating cash flow was $264.00M and free cash flow was $51.00M. The quarter ended Sep 30, 2026 had revenue of $1.54B and net income of $196.00M.
Revenue and Margins
The operating margin was -1.1% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $5.40B, a compound annual rate of 0.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $5.81B | +0.4% | 15.5% | -1.1% | -6.6% |
| Dec 2024 | $5.78B | -4.9% | 19.8% | 5.5% | 1.2% |
| Dec 2023 | $6.08B | -11.0% | 21.4% | -4.0% | -4.1% |
| Dec 2022 | $6.83B | +7.7% | 23.7% | 11.3% | 8.5% |
| Dec 2021 | $6.34B | +27.7% | 21.8% | 10.7% | 9.6% |
| Dec 2020 | $4.97B | -10.1% | 21.5% | 7.4% | 4.4% |
| Dec 2019 | $5.53B | -16.8% | 19.2% | 6.3% | -0.9% |
| Dec 2018 | $6.64B | +7.4% | 29.7% | 17.8% | 15.0% |
| Dec 2017 | $6.18B | +14.5% | 28.2% | 15.9% | 12.1% |
| Dec 2016 | $5.40B | N/A | 20.4% | -1.7% | 0.1% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income rose 326.1% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.81B | $5.78B | $6.08B | $6.83B | $6.34B | $4.97B | $5.53B | $6.64B | $6.18B | $5.40B |
| Cost of revenue | $4.91B | $4.64B | $4.78B | $5.21B | $4.96B | $3.90B | $4.46B | $4.67B | $4.44B | $4.30B |
| Gross profit | $902.00M | $1.14B | $1.30B | $1.62B | $1.38B | $1.07B | $1.06B | $1.97B | $1.75B | $1.10B |
| Research and development | $108.00M | $109.00M | $108.00M | $118.00M | $107.00M | $93.00M | $80.00M | $82.00M | $81.00M | $81.00M |
| Operating income | -$64.00M | $319.00M | -$245.00M | $772.00M | $676.00M | $367.00M | $348.00M | $1.18B | $981.00M | -$94.00M |
| Net income | -$386.00M | $69.00M | -$252.00M | $578.00M | $608.00M | $219.00M | -$52.00M | $996.00M | $747.00M | $7.00M |
| EBITDA | $313.00M | $631.00M | $164.00M | $1.14B | $1.17B | $717.00M | $375.00M | $1.64B | $1.38B | $473.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.54B | $1.59B | $1.38B | $1.33B | $1.50B | $1.61B | $1.37B | $1.36B | $1.51B | $1.55B | $1.36B | $1.41B |
| Gross profit | $231.00M | $286.00M | $212.00M | $155.00M | $233.00M | $278.00M | $236.00M | $264.00M | $286.00M | $308.00M | $284.00M | $251.00M |
| Operating income | $229.00M | -$213.00M | $26.00M | -$6.00M | $81.00M | -$192.00M | $53.00M | $60.00M | $19.00M | $125.00M | $115.00M | -$5.00M |
| Net income | $196.00M | -$274.00M | -$29.00M | -$62.00M | $46.00M | -$379.00M | -$5.00M | -$13.00M | -$32.00M | $60.00M | $54.00M | -$33.00M |
Balance Sheet
As of Dec 2025, total debt of $4.14B exceeded cash and equivalents by $3.47B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.38B | $7.51B | $8.24B | $7.64B | $7.55B | $7.08B | $7.26B | $7.36B | $7.29B | $3.82B |
| Current assets | $3.00B | $3.02B | $3.84B | $3.21B | $3.35B | $2.63B | $2.78B | $3.29B | $3.49B | $902.00M |
| Cash and equivalents | $670.00M | $713.00M | $1.20B | $1.10B | $1.45B | $1.10B | $943.00M | $1.20B | $1.56B | $902.00M |
| Total liabilities | $7.13B | $6.94B | $7.52B | $6.53B | $6.47B | $6.27B | $6.56B | $6.34B | $6.43B | $0 |
| Short-term debt | $42.00M | $54.00M | $0 | $43.00M | $25.00M | $21.00M | $134.00M | $13.00M | $15.00M | -$11.00M |
| Long-term debt | $4.10B | $4.06B | $3.99B | $3.59B | $3.72B | $4.00B | $4.03B | $3.96B | $4.10B | $3.53B |
| Shareholder equity | $250.00M | $571.00M | $721.00M | $1.11B | $1.08B | $813.00M | $689.00M | $1.01B | $860.00M | $0 |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.29B | $7.15B | $7.27B | $7.38B | $7.57B | $7.49B | $7.39B | $7.51B | $7.46B | $7.25B | $7.98B | $8.25B |
| Total liabilities | $7.14B | $7.20B | $7.05B | $7.13B | $7.27B | $7.25B | $6.81B | $6.91B | $6.80B | $6.52B | $7.23B | $7.51B |
| Cash and equivalents | $698.00M | $671.00M | $563.00M | $670.00M | $613.00M | $502.00M | $464.00M | $713.00M | $596.00M | $604.00M | $0 | $1.20B |
| Shareholder equity | $155.00M | -$49.00M | $215.00M | $250.00M | $298.00M | $237.00M | $579.00M | $604.00M | $657.00M | $723.00M | $753.00M | $737.00M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 19.3% of operating cash flow. Dividends came to 152.9% of it, with no share repurchases.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $264.00M | -$633.00M | $556.00M | $755.00M | $814.00M | $807.00M | $650.00M | $1.14B | $640.00M | $594.00M |
| Capital expenditures | $213.00M | $360.00M | $370.00M | $307.00M | $277.00M | $267.00M | $481.00M | $498.00M | $411.00M | $338.00M |
| Free cash flow | $51.00M | -$993.00M | $186.00M | $448.00M | $537.00M | $540.00M | $169.00M | $642.00M | $229.00M | $256.00M |
| Dividends paid | $78.00M | $149.00M | $148.00M | $155.00M | $165.00M | $168.00M | $164.00M | $148.00M | $22.00M | $22.00M |
| Share repurchases | $0 | $0 | $69.00M | $495.00M | $173.00M | $0 | $322.00M | $644.00M | $106.00M | $0 |
| Investing cash flow | -$206.00M | -$353.00M | -$229.00M | -$284.00M | $220.00M | -$234.00M | -$483.00M | -$487.00M | -$370.00M | $357.00M |
| Financing cash flow | -$126.00M | -$36.00M | $172.00M | -$686.00M | -$554.00M | -$449.00M | -$419.00M | -$993.00M | $352.00M | -$396.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $149.00M | $158.00M | -$44.00M | $137.00M | $146.00M | $93.00M | -$112.00M | $138.00M | $139.00M | -$620.00M | -$290.00M | $482.00M |
| Capital expenditures | $51.00M | $44.00M | $49.00M | $45.00M | $41.00M | $43.00M | $84.00M | $109.00M | $76.00M | $73.00M | $102.00M | $135.00M |
| Free cash flow | $98.00M | $114.00M | -$93.00M | $92.00M | $105.00M | $50.00M | -$196.00M | $29.00M | $63.00M | -$693.00M | -$392.00M | $347.00M |
Frequently Asked Questions About CC
What is Chemours' annual revenue?
Chemours reported revenue of $5.81B for the fiscal year ended Dec 31, 2025.
How fast is Chemours' revenue growing?
Revenue was up 0.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -5.3%.
Is Chemours profitable?
No. Chemours reported net income of -$386.00M for the fiscal year ended Dec 31, 2025, with a net margin of -6.6%.
How much free cash flow does CC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $264.00M minus capital expenditures of $213.00M produced free cash flow of $51.00M.
How much debt does Chemours have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $4.10B, short-term debt of $42.00M and cash and equivalents of $670.00M.
CC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors